| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2001 | US20010006974 Combination therapy for lymphoproliferative diseases |
| 07/05/2001 | US20010006973 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 07/05/2001 | US20010006972 Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome |
| 07/05/2001 | US20010006971 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-HT7 receptors |
| 07/05/2001 | US20010006970 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 07/05/2001 | US20010006968 Use of ophthalmic agent |
| 07/05/2001 | US20010006967 Administering an analgesic amount of tramadol and an amount of an excitatory opioid receptor antagonist, e.g naltrexone, nalone, to lessen the antianalgesia, hyperalgesia, hyper-excitability, physical dependence and or tolerance |
| 07/05/2001 | US20010006966 Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action |
| 07/05/2001 | US20010006965 E.g., alpha-(1-((4-methylsulfonylbenzylidene)-2-methyl-5-fluoro-inden-3-yl)acetic acid or the methyl ester |
| 07/05/2001 | US20010006963 Containing estrogenic and gestagenic components; drug delivery; time-release agents; reliable contraceptive effect; osteoporosis pevention; tolerance and cycle control |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | US20010006960 Human or veterinary medicine, especially horses, involving lameness with an osseous, articular or osteoarticular component and not involved with arthritus or fractures; no increase in bone density; e.g., tiludronic acid and salts |
| 07/05/2001 | US20010006959 Displaying a beta-lactamase inhibitor protein on a virus, contacting the virus with a beta-lactamase binding protein target, selecting for the virus that has a higher affinity for the target and testing the beta-lactamase inhibitor protein |
| 07/05/2001 | US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006946 Improved gene transfer efficiency by coadministering with a cholic acid or deoxycholic acid amide derivative of given formula |
| 07/05/2001 | US20010006944 Treating noninvasive fungus-induced rhinosinusitis by mucoadministering an antifungal agent; culturing noninvasive fungus from a mammalian mucus sample for antigen/antibody production; apparatus for collecting nasal mucus |
| 07/05/2001 | US20010006941 Composition for inhibiting increase of blood sugar level or lowering blood sugar level |
| 07/05/2001 | US20010006817 Cell delivery compositions |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006784 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
| 07/05/2001 | US20010006682 Administering parenterally to the patient having suppressed immune system, an effective treatment amount of Product R, a peptide-nucleic acid preperation, alone or in combination with one or more immuno-modulators |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006674 Mixture for use as wound dressing |
| 07/05/2001 | US20010006673 Feeding the animal(dog or cat) a diet containing an effective amount of lutein for a time sufficient for the lutein to be absorbed into the bloodstream of the animal |
| 07/05/2001 | US20010006671 Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements |
| 07/05/2001 | US20010006669 An antiseptic sealed package of solid dry admixed polyvinylpyrrolidone-cinnamic alcohol emulsion, the external surface of emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon |
| 07/05/2001 | US20010006662 A lipid regulating agent selected from a fibrate or statin dispersed or dissolved in a hydrophilic, amorphous polymer in which antilipidimic agent present as metastable, amorphous phase |
| 07/05/2001 | US20010006655 Process for preparing solid formulations of lipidregulating agents with enhanced dissolution and absorption |
| 07/05/2001 | US20010006649 Stable oral pharmaceutical dosage forms |
| 07/05/2001 | US20010006644 Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | US20010006635 Decreasing localized inflammatory responses in a tissue of a patient by administering to said patient heparinase enzyme in an effective amount sufficient to decrease said localized inflammatory response |
| 07/05/2001 | US20010006625 Comprising one or more glucocorticoids, physiologicall tolerable solvent(s), and water insoluble film-forming agents |
| 07/05/2001 | US20010006620 Such a hirudin or oral thrombin inhibitor, by determining from the ratio of the dose given to the measured ecarin clotting time using a computer statistical analysis program |
| 07/05/2001 | US20010006619 Compounds for cancer imaging and therapy |
| 07/05/2001 | US20010006616 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 07/05/2001 | US20010005930 Method of making a hollow-tube precursor brachytherapy device |
| 07/05/2001 | DE19963319A1 Orale pharmazeutische Zubereitung An oral pharmaceutical preparation |
| 07/05/2001 | DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 07/05/2001 | DE19962901A1 Azolylalkalylazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel Azolylalkalylazol-derivatives, processes for their preparation and their use as pesticides |
| 07/05/2001 | DE19960924A1 Amphiphile Polyamine, deren Anwendungen und Verfahren zu ihrer Synthese Amphiphilic polyamines, their applications and methods for their synthesis |
| 07/05/2001 | DE19960443A1 Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen A method for finding nucleotide synthesis inhibitors with fewer side effects |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396713A1 Novel bisamidate phosphonate prodrugs |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396533A1 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 07/05/2001 | CA2396516A1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2396380A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 07/05/2001 | CA2395996A1 Neuroprotective drug |
| 07/05/2001 | CA2395993A1 Antidiabetic preparation for oral administration |
| 07/05/2001 | CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395575A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | CA2395561A1 Benzophenone glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | CA2395557A1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | CA2395548A1 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | CA2395544A1 Method of achieving persistent transgene expression |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395535A1 Method for the production of vitamin a |
| 07/05/2001 | CA2395524A1 Chemotherapeutant screening method |
| 07/05/2001 | CA2395430A1 Treatment of drug-resistant human immunodeficiency virus infection |
| 07/05/2001 | CA2395418A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | CA2395410A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | CA2395345A1 Use of azoles for preventing skin cancer |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395320A1 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | CA2395305A1 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395276A1 Identification of novel splice variants of the human catalytic subunit c.beta. of camp-dependent protein kinase and the use thereof |
| 07/05/2001 | CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | CA2395273A1 A novel isoform of human camp-dependent protein kinase, c.alpha.-s, localizes to sperm midpiece and the use thereof |
| 07/05/2001 | CA2395259A1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 07/05/2001 | CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395205A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 07/05/2001 | CA2395179A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/05/2001 | CA2394888A1 Compound and method for the treatment of pain |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394747A1 Use of trimebutine for treating pain |
| 07/05/2001 | CA2394745A1 Combination of trimebutine with an opioid analgesic |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments |
| 07/05/2001 | CA2394561A1 Method and composition for the treatment of pain |
| 07/05/2001 | CA2394393A1 Remedies for external use for allergic skin diseases |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | CA2393916A1 Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |